Omega Fund Management is a private equity general partner firm headquartered in London, United Kingdom and has other offices in United States.
Anaconda Biomed, a pre-clinical stage medical device company, has raised €15m in Series A from Ysios Capital, Omega Funds and others.
VC-backed Editas Medicine, a company that aims to treat diseases through gene editing, has raised $94.4m through its IPO.
Editas Medicine, a genome editing firm, has raised $120m in Series B funding led by Boris Nikolic, with the participation of others VCs.
Read more news concerning Omega Fund Management
A sampling of Omega Fund Management portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?